Furthermore, PREX2 and GRIN2A mutations were significantly more prevalent in melanomas with mitosis [p = 0.042; OR = 4.0 (1.0–15.4) and p = 0.023; OR = 6.2 (1.3–29.5), respectively]. The gene discussed is PREX2; the disease is melanoma.